The contractility of corporal smooth muscle plays a critical role in the entire erectile process in man. Moreover, in the absence of severe vascular disease, or congenital or other structural abnormalities/malformations, relaxation of the corporal smooth muscle is both necessary and suf®cient to elicit a sustained erection. As such, understanding the initiation, maintenance and modulation of corporal smooth muscle tone is an absolute prerequisite to the improved understanding, diagnosis and treatment of erectile dysfunction. Despite this fact, identi®cation of both the precise mechanistic basis by which endogenous and exogenous vasomodulators exert their effects on individual corporal smooth muscle cells, and moreover, the process by which these signals are spread among the diverse array of parenchymal cells in the paired corpora, remains somewhat of a physiological enigma. Therefore, the goal of this report is two-fold: ®rst, to review current knowledge of the regulation of corporal smooth muscle tone at the cellular and molecular level; and second, to outline a cogent explanation for the rapid and syncytial integration of the effects of diverse stimuli among corporal smooth muscle cells in the human penis.
The physiology of erection As recently described 1 for approximately 23 h each day the penis of most adult men is in the¯accid state. It is only during rapid eye movement dream sleep, or sexual or re¯ex stimulation that the penis becomes erect. This rapid shift of physiologic status, from¯accid to erect, is a result of the complex integration of responses occurring throughout the penile neurovascular network. In this scenario, large volumes of blood can be rapidly shifted from, or stored in, the penis within a few seconds. The majority of smooth muscle cells of the penis lie outside the cavernous and helicine arteries of the penis, and are enmeshed in a collagen-containing trabecular network of cavernous.
2±4 During¯accidity the corporal smooth muscle exists in a partially contracted state, and the blood is supplied to the corpora via the paired cavernous arteries. As such, blood¯ows preferentially from the cavernous arteries, through the small nutrient vessels of the trabecular network, to the emissary veins and subsequently out of the corpora. Following corporal smooth muscle relaxation, blood¯ow is preferentially shifted from the cavernous arteries and nutrient arterioles through the helicine vessels to the sinusoidal spaces. Relaxation of the corporal smooth muscle signi®cantly increases the compliance of the trabecular meshwork, and ensures the maximally effective transmission of systolic blood pressure required to occlude blood¯ow through the small, subtunical emissary veins. During erection the blood¯ow in the penis increases from a relatively low level of 5 ml/min, with a concomitant intracorporal pressure of 5±8 mm Hg, to a much higher blood¯ow of 50±80 ml/min and a corresponding pressure roughly equal to the mean systolic blood pressure. Upon achievement of rigidity, blood is actually stored in the sinusoids at a very low¯ow rate, and thus, the penis becomes fully erect. As such, the corporal smooth muscle cells serve a capacitive; 5 that is, when they are contracted the penis is a low pressure, low¯ow organ with blood preferentially shunted from the erectile spaces, and conversely, when they are relaxed the blood is fed into the sinusoidal spaces, creating a high pressure, closed system.
The aforementioned description emphasizes the critical importance of the corporal smooth muscle cells in modulating erection, detumescence and accidity in the human penis, and moreover, high-lights the necessity for understanding the initiation, intracellular transduction and parenchymal spread of the largely locally restricted neural signals that are a hallmark of the erectile process. As illustrated in Figure 1 , coordination of the erectile process can be broken into three general phases: (1) Autonomic neural activation, (2) Corporal and arterial smooth muscle activation (intracellular signal transduction), and, (3) Integration of the response among the vast array of smooth muscle cells via intercellular communication through gap junctions. These three phases will be considered in order below. Figure 1 Flow chart depicting the salient features of integrative erectile biology. As illustrated, erectile function has been divided into three broad phases. Phase 1 involves activation of the autonomic nervous effector pathway, by any one of a variety of known mechanisms, resulting in release of neurotransmitter/neuromodulator from synaptic varicosities around blood vessels and throughout the corporal parenchyma. Phase 2 consists of two distinct parts. Phase 2A consists of diffusion of neurotransmitter to the smooth muscle membrane bound receptor sites (or in the case of NO 7 , diffusion across the smooth muscle cell membrane), and activation of the corresponding second messenger pathway (namely IP 3 /DAG, cAMP, cGMP, etc.). Phase 2B consists of the effects of the increased second messenger levels on intracellular events; namely these would be effects on junctional and especially nonjunctional ion channels (K and Ca 2 ), but of course phosphorylation/activation of proteins/enzymes that effect other regulatory pathways might also be important (for example myo®lament calcium sensitivity or other calcium sequestration/extrusion or release mechanisms; see text). Phase 3 involves spread of the cellular activation process to adjacent, coupled smooth muscle cells via intercellular communication through gap junctions. Ultimately resulting in synchronous tissue activation; in this particular case, coordinated contraction or relaxation of corporal and arterial smooth muscle. Phase 1. The autonomic nervous system (ANS): a primary site of signal origination in corporal and arterial smooth muscle
The complex physiologic cascade responsible for corporal erectile function requires precise modulation of central and peripheral neural pathways, as well as the integrity of the penile vasculature. Anatomically, neural control of penile erection can be divided into four broad categories: (1) sympathetic, (2) parasympathetic, (3) sensory, and (4) somatic. Of course the integrity of all four pathways is required for normal penile erection. However, the importance of the somatic and sensory pathways to regulation of the erectile process have been discussed in much detail in recent reviews, 2±4 and will not be further discussed here. As such, this report will focus solely on the role of the autonomic nervous system in modulating corporal and arterial smooth muscle tone.
Autonomic innervation of corporal smooth muscle
As described above, the autonomic nervous system consists of two anatomically distinct pathways the sympathetic and parasympathetic pathways, respectively. Pre-ganglionic parasympathetic nerves are myelinated and originate from the somata of cranial and sacral nerves. Post-ganglionic parasympathetic nerves which are non-myelinated, and synapse at or near the tissues which they innervate. Sympathetic pre-ganglionic nerves are also myelinated, and originate from nuclei which reside in the thoracic and upper lumbar spinal column. The cell bodies of post-synaptic sympathetic nerves primarily originate in the sympathetic trunk; sympathetic, postganglionic nerves are far longer than their parasympathetic counterparts.
The pelvic origin of penile innervation lies in visceral efferent parasympathetic pre-ganglionic ®bers from the second through fourth sacral roots, and the sympathetic post-ganglionic ®bers from thoracolumbar ganglion T12-L2. Parasympathetic input from the pelvic splanchnic nerves, and sympathetic input via the super®cial hypogastric nerves help form the pelvic plexus. The dual autonomic innervation from the pelvic plexus sends visceral branches to the corpora cavernosa, termed the cavernous nerves.
Both of these anatomical classi®cations, can in turn, be further subdivided according to the neurotransmitter/neuromodulator released into the corporal milieu. In general then, with respect to the control of corporal and arterial smooth muscle tone, the most physiologically relevant autonomic effector pathways thus characterized are: (1) sympathetic adrenergic constrictor nerves which directly increase corporal and arterial smooth muscle tone; (2) parasympathetic nonadrenergic/noncholinergic nerves which directly decrease arterial and corporal smooth muscle tone (primarily nitric oxide and VIP; 4, 6 and (3) an additional parasympathetic cholinergic pathway which indirectly modulates tone by altering sympathetic input.
Characteristics of the autonomic neuromuscular junction in corporal tissue
The distribution of autonomic nerves in the corpora consists primarily of perivascular and parenchymal nerves. Both of these are easily demonstrable in the corpora, although the former appears to predominate. With respect to the latter, the bulk of erectile tissue is made up of smooth muscle bundles, within which are widely distributed effector nerve ®bers.
As illustrated in Figure 2 , near effector tissues, the terminal axons become varicose; that is, the last few axons are devoid of schwann cells. The essential feature of the terminal axon is the neuromuscular junction, where neurotransmitter is released from varicosities during nerve impulse conduction. The junction between terminal varicosities and smooth muscle cells is highly variable in both con®guration and distance. Thus, smooth muscle cells in close proximity to nerve varicosities are likely to be directly affected by the released neurotransmitter; while more distal cells within smooth muscle bundles are likely to be activated indirectly by propagation of electrical or chemical activity through gap junction channels 3, 7 (see text below).
Synthesis/disposition of prominent autonomic neurotransmitters in the corpora
There are clearly a plethora of neurotransmitters present in the human corpora, and this has recently been reviewed in much detail. However, for the sake of clarity and simplicity, this report will focus on a detailed presentation of only a few prominent neurotransmitters. These are, adrenergic (norepinephrine), cholinergic (acetylcholine) and nonadrenergic, non-cholinergic (NANC; nitric oxide and vasoactive intestinal polypeptide).
Adrenergic and cholinergic neurotransmitters
The primary neurotransmitter of cholinergic nerves is acetylcholine (Ach), whose synthesis takes place in the autonomic neuronal cell body and the peripheral axon terminal. Ach is stored in vesicles and released by exocytosis into the neuromuscular cleft. Ach is hydrolyzed to choline, which is taken up at the endplate. The captured choline is thought to be important in maintaining continued neurotransmitter synthesis. 8 Noradrenaline is stored in granular vesicles together with dopamine B-hydroxylase and chromogranin A. Noradrenaline is also released by exocytosis. Following activation at the post-synaptic muscle membrane, noradrenaline is re-incorporated at the nerve terminal, if not degraded by MAO or COMT. 8 
Non-adrenergic, non-cholinergic (NANC) neurotransmitters
Non-adrenergic, non-cholinergic nerves use multiple transmitter substances, the two most prominent in the corpora appear to be vasoactive intestinal polypeptide (VIP) 4, 9 and nitric oxide (NO
7
). 4, 10 With respect to the former, as reviewed elsewhere, 4 several immunohistochemical studies have demonstrated the presence of VIP in autonomic nerves in the smooth muscle and penile blood vessels of the human corpus cavernosum. With respect to the latter, NO 7 is produced by the enzyme NOS (nitric oxide synthase, which is distributed in NANC nerves throughout the corpora. NO 7 is produced as the enzymatic by product of molecular oxygen (O 2 ) and L-arginine, which, as mentioned above, is catalyzed by NOS. NO 7 is an interesting neuromodulator/neurotransmitter in that it is highly lipophillic, with a very short half-life ( % 5 s), and a concomitantly limited radius of diffusion. 11 Moreover, NO 7 is synthesized`on demand' and is not known to be stored by any mechanism in any appreciable amounts in NANC nerves, or elsewhere.
Release of neurotransmitters at the autonomic neuromuscular junctions (NMJs)
The neuromuscular junction is one site at which the delicate balance between vasoconstricting and vasodilating agents is readily apparent. Adrenergic and cholinergic nerve terminals are in close proximity to each other and the smooth muscle cells they innervate; although as described above, the majority of varicosities do not form`classical' synaptic clefts with the adjacent smooth muscle cells. In addition, the wide conformational variability of the neuromuscular cleft is likely indicative of the versatility of the autonomic neuromuscular junction. The phenomenon of co-transmission, i.e. the release of more than one neurotransmitter/neuromodulator from a particular neuron is well recognized, and likely to be very important; although it certainly represents a very poorly characterized phenomenon with respect to penile erection 3 . As such, it is conceivable that co-transmission and/or alterations in co-transmission could turn out to be an important regulatory site for erectile physiology and dysfunction. For example, certain substances may act via their own receptors/effectors to produce synergistic actions with other more principal neurotransmitters, for example as has been proposed for VIP and NO
7
). In fact, it has been shown that the number of VIPergic nerves providing vasodilatory control of penile smooth muscle are reduced or lost entirely in diabetic neuropathy associated with erectile dysfunction. 12 As such, it is very important to emphasize that one must look beyond the neuromuscular junction to see both the macro and microcellular effects of altered neurotransmission, and their concomitant effects on erectile vascular physiology/function. 3, 13 There is no doubt that this is clearly a fruitful area for future research.
A related phenomenon is neuromodulation. This represents another important aspect of erectile neurophysiology that occurs at the NMJ, and has heretofore received little recognition or investigation 3 . Speci®cally, alterations in the amount of neurotransmitter/neuromodulator released by neurons, as well as the timing of neurotransmitter release/binding/activity at the neuromuscular junction may have a dramatic effect not only on adjacent Figure 2 Schematic depiction of the general geometry/topology of the autonomic neuromuscular junction in corporal smooth muscle. Panel A. As illustrated, nerve terminals in the corporal parenchma, as well as around blood vessels, become unmyelinated and varicose. These varicosities are thought to be the site of release of neurotransmitter in this and other peripheral tissues. As illustrated, varicosities coursing through a group of smooth muscle cells give the appearance of`beads on a string'. Release of neurotransmitter will result in graded activation of smooth muscle cells in direct relation to their proximity to the varicosity (regardless of whether the relevant pathway is extracellular or intercellular; although as discussed in the text, there is compelling evidence in favor of the latter). Although not depicted, the cells are interconnected by gap junctions, so that direct activation of membrane receptors on cell #1, would result in increases in intracellular second messenger levels, the effects of which, could be transmitted by the intercellular pathway to cells 2, 3 and 4. Obviously, it is dif®cult to illustrate a 3-D effect in two dimensions, thus, one should keep in mind that a similar scenario applies for all possible planes of diffusion (for example on the Z axis in and out of the page). Also note that since cytoplasmic diffusion is approximately one order of magnitude greater than junctional permeability, intercellular diffusion will be faster along the long axis of the smooth muscle cells, than across the width of the smooth muscle cells (namely anisotropic). Such anisotropic diffusion may have important implications to erectile physiology/dysfunction, depending on the particular arrangement of smooth muscle cells within the corpora. Panel B shows a schematic diagram of how activation of one cell (namely the far left cell #1) could lead to recruitment of adjacent, but not directly activated cells via the passive intercellular spread of second messenger molecules/ions. Such a mechanism is important to permit coordination of corporal smooth muscle tone; note that this would be true whether this cellular activation results from the release of a locally restricted neuronal or endothelial signal, or from the intracorporal injection of a vasorelaxant (see text). Note that when intercellular diffusion is truly passive, it will result in a second messenger gradient across an array of smooth muscle cells; with the cells nearest the activated cell`seeing' much higher second messenger concentrations than more distally removed cells. As such, the`sensitivity' or corporal smooth, muscle cells to these intracellular messengers (namely the amount or concentration of second messenger required for cellular activation) will be a very important determinant of the size of the`active vascular unit' (see text). Panel C illustrates the predicted intercellular diffusion pro®les on the same cells depicted in B (that is, the numbers on panel C correspond to same cells numbered in panel B). These intercellular diffusion pro®les of junction permeant second messenger molecules were calculated by mathematical modeling techniques. 35 Brie¯y, for this calculation, cell 1 is assumed to have some arbitrary, but constant, concentration of second messenger molecules due to persistent receptor activation by agonist or neurotransmitter. Thus, the model depicts the expected passive diffusion of second messenger molecules from cell one to as many as ®ve cells distantly removed. The arrows in the diffusion pro®le emphasize the differential intercellular second messenger concentrations expected across the junctional membrane of contiguous cells, while the dashed lines depict the anticipated concentration gradients across the width of the cell. The junctional permeability used for this comparison was 5610 74 cm/sec, a junctional permeability characteristic of well-coupled corporal smooth muscle cells expressing the gap junction protein connexin43.
neurons, but also on the corporal smooth muscle cell. There are two obvious examples of the importance of neuromodulation to erectile function. The ®rst is nitric oxide, whose synthesis via the nitric oxide synthase enzyme (see text below) has not only more than one source cell (namely neurons and endothelial cells) but perhaps additionally, both constitutive and inducible components as well.
14 A second relevant example of the potential physiological relevance of neuromodulation is the hypothesis advanced by Christ and coworkers, 15, 16 in which endothelin-1 (ET-1), also synthesized by more than one cell type (smooth muscle cells, as well as endothelial cells) is proposed to augment the effects of underlying adrenergic tone via its direct effects on corporal smooth muscle cells; moreover, there is likely to be a reciprocal relationship between ET-1 and the nitric oxide levels. As such, neuromodulation may be an especially important consideration to erectile physiology.
Phase 2A. Activation of corporal and arterial smooth muscle
Control of corporal smooth muscle contraction and relaxation
Ultimately, activation of corporal smooth muscle cells, either contraction or relaxation, is mediated by the rise and fall, respectively, in the free intracellular calcium levels; although alterations in myo®la-ment calcium sensitivity have also been proposed. 17 As such, both dynamic alterations in (namely erection and detumescence), as well as sustained (tonic) contraction (namely¯accidity) of, corporal smooth muscle are ultimately controlled, in large part, by the effects of various endogenous (namely neural or hormonal) and exogenous (intracavernous injection of vasoactive compounds) substances on the free intracellular calcium ion 3, 7, 15, 16 ,18±20 (see Figure 1 for details). Still, in the partially contracted state of the corporal smooth muscle cell, as in other vascular tissues, 17 small¯uxes of Ca 2 ion presumably continually enter the cell through L-type voltage dependent Ca channels on the cell membrane. Subsequently, the calcium ion is distributed/ stored within the sarcoplasmic reticulum, cytoplasm and the nucleus of the cell. In light of the importance of intracellular calcium homeostasis to the control of corporal smooth muscle tone, and thus, penile erection, we review the effects, again, of prominent vasomodulators only, on intracellular calcium levels, and thus, corporal smooth muscle tone and erectile capacity.
Regulation of contraction of corporal smooth muscle by intracellular calcium levels
Contraction of corporal smooth muscle may be elicited by activation of a membrane receptor subsequent to occupancy of the receptor by substances found in the adjacent plasma or by neurotransmitters released from autonomic nerves ®bers in the region of the smooth muscle cell. As illustrated in Figure 3 , the precise mechanism of action is presumably similar to that demonstrated for other smooth muscles; although it should be emphasized that all aspects of this have not been unequivocally established in corporal smooth muscle. Activation of the appropriate membrane receptor leads, through a G protein-dependent mechanism, to the cleavage of phosphatidylinosotil bisphosphate (PIP 2 ), liberating inositoltrisphosphate (IP 3 ) and diacylglycerol (DAG). The former is responsible for liberation of intracellular calcium from the sarcoplasmic reticulum, while the latter leads to activation of protein kinase C, and subsequent phosphorylation events; it is important to note that phosphorylation events are thought to be linked to both alterations in membrane ion channel activity (both K and Ca channels; see below), and perhaps alterations in myo®lament calcium sensitivity; the latter would ensure that so long as the agonist signal remains, even when the intracellular calcium concentrations return to near resting levels, the smooth muscle cell would remain in the contractile state.
More speci®cally, activation of both the a 1 -adrenergic and ET A -receptor subtypes (by phenylephrine (PE) and endothelin-1 (ET-1), respectively) in human corporal smooth muscle have been documented to elicit a rapid and transient elevation in the intracellular calcium concentration in cultured human corporal smooth muscle cells; 15,20 the latter, but not the former, has been shown to be coupled to increased IP 3 metabolism (Christ et al, unpublished observations). Moreover, as the measured increases in the peak amplitude of the intracellular calcium transient in the cultured smooth muscle cells occur over the same concentration range as the increase in the magnitude of the steady-state contractile response, 15, 16 this has been taken as further evidence of the major importance of intracellular calcium to the modulation of corporal smooth muscle tone elicited by these two endogenous agonists.
Regulation of corporal smooth muscle relaxation
Functional (physiological) antagonism of intracellular calcium levels/myo®lament calcium sensitivity is the primary mechanism responsible for relaxation of smooth muscle. In this regard, there are two main intracellular messenger molecules that modulate the continuous transmembrane calcium ux through voltage-dependent calcium channels that is so critical to the sustained contraction of corporal smooth muscle (see Figs. 3 and 4) . These are, respectively, the intracellular concentrations of the second messenger molecules cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP).
With respect to the former, increases in intracellular cAMP levels represents the primary mechanism by which most intracavernous injection agents mediate their effects, for example, prostaglandin E 1 and papaverine. With respect to the latter, increases in intracellular cGMP levels are thought to be the primary mechanism by which NO 7 released from NANC nerves exerts its relaxant actions, subsequent to activation of soluble guanylate cyclase. Increases in either cAMP or cGMP levels, in turn, result in activation of protein kinase A and G, respectively; although recent in vitro data suggests that there may well be cross-talk between cAMP and cGMP effector pathways (namely cAMP could activate G kinase, and vice versa), and/or the presence of an additional, as yet unidenti®ed kinase. 21±24 The physiological actions of increased intracellular second messenger levels are summarized in Figure 3 and described below.
Phase 2B. Alterations in the activity of K channels and their effects on corporal smooth muscle tone
The most widely utilized form of intracavernous pharmacotherapy relies on receptor-mediated in- ion¯ux is controlled by three main effector pathways, the ®rst two are the cAMP/PKA (PKA; protein kinase A) and cGMP/PKG (protein kinase G) pathways which are activated by, for example, PGE 1 and NO 7 , respectively, and while these pathways apparently modulate the activity of the maxi-K channel; their effects on the K ATP channel have not been documented, but seem likely. A third pathway is the potassium channel modulators, which exert their relaxant actions on corporal smooth muscle, at least in part, by altering the activity of the K ATP channel. Because of the disposition of K and Ca 2 ions in the intra-and extracellular spaces (see Figure 4) , the opening of Ca 2 channels leads to the in¯ux of Ca 2 down it's electrochemical gradient and subsequent intracellular depolarization, while the opening of K channels lead to ef¯ux of K from the cell down its electrochemical gradient, and subsequent intracellular hyperpolarization. The effects of these reciprocal pathways on membrane potential and the level of corporal smooth muscle tone are exerted, at least in part, through modulation of the intracellular calcium concentration; with increases in intracellular calcium associated with contraction, and decreases in intracellular calcium associated with relaxation. Although not shown, the cAMP/PKA and cGMP/PKG pathways are thought to have an inhibitory effect on Ca 2 channel activity (namely decreased open probability); presumably through phosphorylation effects, as well as the effects of membrane potential changes. Where (): denotes a positive or stimulatory effect; (7) A more novel approach has been the use of the diterpine plant alkaloid forskolin, 25, 26 which directly activates the adenylate cyclase enzyme to produce increased intracellular cAMP levels; again, independent of receptor activation, although synergistic with it. While a more detailed discussion of these methods/techniques is clearly beyond the scope of this report, suf®ce it to say, that alterations in the activities of various protein kinases and/or ion channels is now possible, and the possibility of genetic therapies for the treatment of erectile dysfunction are clearly on the horizon. However, the major draw back to any such pharmacological/ genetic treatments is that while they do have some selectivity for their end organ effects/target sites, there is still much room for improvement with respect to their absolute speci®city of action.
Potassium channels as a convergence point for modulating corporal smooth muscle tone and erectile capacity Potassium channels have been shown to play a fundamental role in both the physiologic and pathophysiologic regulation of smooth muscle tone. These channels act as a convergence point for modulation of a number of receptor and effector systems. In addition to both affecting basal tissue tone, as well as the initiation and termination of a contractile stimulus, potassium channel activity effects corporal tissue relaxation, particularly with respect to responses that are dependent on hyperpolarization. As illustrated in Figure 4 , any intracellular second messenger effect that is associated with increased K channel activity/mean open time will result in an increased potassium ion ef¯ux from the cell interior. This in turn causes cellular hyperpolarization which reduces calcium ion in¯ux through a decreased activity/mean open time of voltage-dependent calcium channels (smooth muscle cell relaxation erection). With respect to the latter, elevations in intracellular cAMP 2 and perhaps cGMP as well, have a dual effect. They may contribute not only to direct alterations in K channel activity, but they might also affect the disposition and integrity of intracellular calcium stores and/or the sensitivity of contractile myo®laments to intracellular calcium. All of these actions will, of course, promote smooth muscle relaxation.
In this regard, potassium channels exhibit greater diversity than any other nonjunctional ion channel. Furthermore, the K ATP and maxi-K potassium channel subtypes are thought to be the most physiologically relevant K channels expressed in corporal smooth muscle. The salient features of these channels are described below.
The maxi-K channel subtype
The maxi-K channel (K Ca ) subtype, is similar to the calcium-sensitive K channel present in many smooth muscle cell types. 7, 27, 28 It is clearly the predominant K channel subtype found in corporal smooth muscle, and is responsible for approximately 90% of the observed whole cell outward K currents seen in cultured human corporal smooth muscle cells. The maxi-K channel appears to have signi®cant activity near and even below the mean resting membrane potential suggesting that it may be an important modulator of membrane potential; in corporal smooth muscle cells. Moreover, patch clamp experiments conducted on cultured corporal smooth muscle cells indicate that the activity of the maxi-K channel is increased by both the addition of NO donors (namely nitroglycerine; Christ et al, unpublished observations), as well as addition of PGE 1 and the Schwarz/Pharma inclusion complex, PGE 1 -a-CD. 29 In addition, the increase in maxi-K channel activity produced by agents such as PGE 1 , is correlated with a signi®cant alteration in the peak amplitude of the ET-1 induced intracellular calcium transient seen in fura-2 loaded cultured corporal smooth muscle cells. 30 Speci®cally, pre-incubation of cultured human corporal smooth muscle cells with PGE 1 resulted in an approximately 40% decrease in the peak amplitude of ET-1 induced calcium transient. The observed decrease in the ET-1-induced intracellular calcium transient is a re¯ec-tion of the inhibition of transmembrane calcium ux; once again highlighting the close association between K channel activity and the activity of voltage-dependent Ca channels.
Recent electrophysiological studies on cultured human corporal smooth muscle cells 28 have also suggested that alterations to the function/regulation/ structure/activity of the maxi-K channel may be characteristic of organic disease per se. Such a supposition is consistent with other recent in vitro experiments conducted on cultured human corporal smooth muscle cells, which suggested that organic disease per se may also be associated with alterations in intracellular calcium mobilization/homeostasis. 30 Finally, studies conducted on isolated human corporal tissue strips are also consistent with the hypothesis that the activity of the maxi-K channel is an important modulator of both phenylephrine (PE)-and ET-1-induced contractile responses in human corporal smooth muscle. 31 As such, it can be seen that the important contribution of the maxi-K channel subtype to the regulation of corporal smooth muscle tone has been proven by multiple pharmacologic/physiologic studies. Perhaps most importantly of all, transfection of the human maxi-K cDNA hSlo in rats in vivo, 32 and humans in vitro, 33 have documented that increased expression of the human maxi-K channel is associated with physiologically relevant alterations in corporal smooth muscle cell function. These results validate the possibility that genetic therapies that result in alterations in post-receptor mechanisms might well represent an attractive therapeutic approach to the treatment of erectile dysfunction.
The K ATP channel subtype
The K ATP channel subtype is another important modulator of corporal smooth muscle tone. Electrophysiological studies have indicated that the K ATP channel subtype in human corporal smooth muscle is apparently similar to the metabolically-regulated K channels found in other smooth muscle cell types. 7, 27 Moreover, pharmacological studies have documented that there is a signi®cant (glibenclamide-sensitive) decrease in the sensitivity of precontracted corporal tissue strips excised from diabetic patients to relaxation by structurally diverse K channel modulators (namely pinacidil, Figure 4 Illustration of the inter-relationship among the known junctional and nonjunctional ion channels that regulate corporal smooth muscle tone; compare with Figure 3 . As illustrated, all of the physiologically relevant second messenger molecules are freely diffusible across the junctional membrane between cells. There exists an important and functionally antagonistic relationship between the activity of Ca nd K channels on corporal smooth muscle. Moreover, the degree of intercellular communication among these cells ensures their partial cytoplasmic continuity. Thus, alterations in ions/second messengers can be quite readily conveyed to adjacent smooth muscle cells. U83757, P1075), when compared to equivalently precontracted rings of corporal tissue obtained from nondiabetic patients. 34 Consistent with these observations, precincubation of fura-2 loaded cultured human corporal smooth muscle cells with pinacidil results in an apparently near complete ablation of transmembrane calcium¯ux in response to addition of ET-1. Such observations provide further evidence for the importance of K channels not only in the modulation of corporal smooth muscle tone, but also, as putative targets of disease. In light of the aforementioned discussion, a review of the principles governing the propagation of vasoactive stimuli among corporal smooth muscle cells seems relevant. This discussion has been saved for last, as a thorough understanding of integrative aspects of corporal biology is very dependent on detailed knowledge of the mechanistic basis for signal origination/transduction in corporal smooth muscle. That being said, a model of integrative corporal tissue function has recently been developed. 35 The explicit underlying assumption of this model is that neuronal innervation (Phase 1), in concert with myogenic intracellular signal transduction mechanisms (Phase 2A and 2B) and intercellular communication through gap junctions (Phase 3), forms a`syncytial tissue triad' that plays a major role in erectile response generation/modulation ( Figure 5 ). The salient features of this model are described below.
How is coordination of corporal smooth muscle responses accomplished?
Clearly much has been learned in the past decade concerning the mechanistic basis for the modulation Figure 5 Schematic diagram depicting the proposed model for integrative erectile biology, known as the syncytial tissue triad. The concept advanced is that the contraction and relaxation responses among the vast network of largely inexcitable corporal smooth muscle cells (nominally the ®nal effectors of erectile capacity) are primarily cordinated by a triumvirate of mechanisms (see text): (1) Innervation: the characteristics of the effector neural pathways in the penis that are responsible for initiating both erection and detumescence (namely innervation density, ®ring rate, etc.); (2) Propagation: those processes (namely intercellular communication through gap junctions) that permit cells not directly activated by a locally restricted neural or hormonal signal to contribute to the ensuing tissue response (namely erection); and (3) Transduction: those intracellular processes that occur following cellular activation (namely intracellular signal transduction pathways). Modi®ed from (2). of corporal smooth muscle tone. However, the process(es) responsible for achieving the rapid and syncytial smooth muscle responses required for normal erectile function are less well understood. As described elsewhere, 13, 27 several contingencies exist for the syncytial activation of corporal smooth muscle: (1) Direct neuronal innervation of every or almost every smooth muscle cell; (2) The presence of electrically excitable smooth muscle cells such that syncytial tissue responses could be achieved by regenerative electrical events triggered by fewer neuromuscular junctions; (3) The passive movement of intercellular second messenger molecules/ions through gap junctions from directly activated cells to distally removed coupled cells, subsequent to activation of only a small fraction of smooth muscle. These possibilities are considered below.
Neuronal innervation of the corpora
Clearly, as described above, the diversity of neurotransmitters present within the corpora re¯ects the complexity of the neuronal innervation of the corpora. While from an anatomical standpoint, there has clearly been no systematic investigation of innervation patterns in the human corpora, it seems certain that the number of smooth muscle cells far exceeds the number of neuronal varicosities (see above). As such, the bulk of human erectile tissue apparently consists of bundles of smooth muscle cells, with the autonomic innervation consisting of widely distributed nerve ®bers rather than intricate neuronal innervation of individual smooth muscle cells. Therefore, it seems unlikely that ANS innervation of the corporal smooth muscle is suf®cient to provide syncytial activation of the corporal smooth cells in the absence of other mechanisms.
Electrical excitability of corporal smooth muscle
A review of some aspects of the electrical properties of human corporal smooth muscle cells in vitro that have recently been described seems prudent. Corporal smooth muscle cells are known to express a variety of membrane ion channels, including potassium channels, 27, 28 calcium channels, 7 and perhaps chloride channels (Christ et al, unpublished observations) as well. Although rigorous characterization of all aspects of the behavior of these nonjunctional membrane ion channels is still lacking, there is certainly no compelling in vitro data that indicate that corporal smooth muscle cells possess any ionic capacity for regenerative electrical events (namely action potentials). Moreover, there is also no ®rm evidence, at either the tissue or cellular level, for the presence of pacemaker cells in human corporal smooth muscle. As such, regenerative electrical events (namely action potentials), or the synchronization of such events by pacemaker cells seem an unlikely scenario for coordinating corporal smooth muscle responses.
The importance of intercellular communication through gap junctions to the local control of penile erection
It is precisely because neither neuronal innervation, nor electrical excitability are suf®cient, by themselves, to account for the syncytial nature of corporal smooth muscle activity, that we have turned out attention to the study of gap junctionmediated intercellular communication. As reviewed below, the anatomical, structural, biochemical, pharmacological and electrophysiological characteristics of connexin43-mediated intercellular communication have been shown to be suf®cient to account for the proposed role of intercellular communication in the physiology of erection in vivo. Thus, it seems likely that intercellular diffusion of second messenger molecules/ions through gap junctions, serves a primary role as a modulator of corporal smooth muscle tone. 3,7,13,20±42 The general anatomical and physiological properties of gap junctions are reviewed below.
Gap junction structure and function
Gap junctions represent a diverse family of related proteins, known as connexins, that are named according to their molecular weights. 43±45 Six, presumably homologous, membrane spanning connexins join to form a connexon, or hemichannel, in the cell membrane. The union of these connexons across the extracellular space, provides an aqueous intercellular channel and, thus, partial cytoplasmic continuity between adjacent cells (see Figure 6) . Moreover, at areas of membrane apposition between adjacent corporal smooth muscle cells, these integral membrane proteins are known to coalesce to form junctional plaques consisting of hundreds of individual channels. This has been documented in human corporal smooth muscle both in vitro and in vivo. 35 While 12 distinct mammalian connexins have been identi®ed, connexin43 appears to be the predominant gap junction protein expressed in human corporal smooth muscle, and thus, it is the only connexin considered here.
Conductance and permeability of connexin43-derived gap junction channels
Electrophysiological studies have documented that connexin43-derived gap junctions can express multiple conductance states, ranging from 30±100 pS (namely predominantly 30, 60 and 90 pS). Furthermore, the distribution of these conductance states has been shown to be modulated by some of the same second messenger molecules described above (for example activation of protein kinase A or C; see Ref. 45 for details). More recently, however, it has been shown that the 100 pS conductance is the most dominant, and additionally, that the high open probability ( b 90%) and characteristically long mean open time (1±5 s), of this channel undoubtedly contributes to its physiological relevance in vivo. 47 In fact, it is precisely these electrophysiological properties that ensure that the permeability of connexin43-derived gap junction channels is suf®-cient to permit the intercellular passage of the majority of physiologically relevant current carrying ions and second messenger molecules. Thus it is not surprising that inositol trisphosphate and/or calcium ions, for example, have been shown to diffuse between cultured corporal smooth muscle cells. 20 As such, intercellular solute diffusion among coupled cells has been postulated to have a major role in the integration and coordination of responses in diverse vascular tissues, 41,48±53 including corporal smooth muscle. 20,37±41,46,47 Sophisticated electrophysiological studies as well as mathematical analyses of such data have been utilized to elucidate important features of junctional communication in the coordination of corporal tissue tone. 48 While a detailed description of these studies is outside the more focused aims of this report, suf®ce it to say that when taken together with the results of recent anatomical, molecular, immunochemical and pharmacological and clinical studies, it appears that the physiological pro®le of gap junctions in vitro is more than suf®cient to confer the requisite properties required of these channels in vivo.
Physiological relevance of intercellular diffusion of second messenger molecules/ions through gap junctions among corporal smooth muscle cells
If every cell could be directly activated by neurotransmitter or drug diffusion through the extracellular space, the intercellular pathway would be arguably physiologically redundant. Thus, in recent publications we have utilized mathematical modeling techniques to address this issue. Our studies have evaluated the anticipated intercellular diffusion of second messenger molecules and current carrying ions through connexin43-derived gap junctions in vascular tissues, 11 and compared these estimates to reasonable expectations for the diffusion of similar size molecules in the extracellular space. 53±55 The details concerning these methods are described elsewhere.
11,46,53±55 In short, the modeling studies indicate that if one assumes that intercellular diffusion is a passive process (namely obeying Fick's law of diffusion), then the pro®le for intercellular transit of second messenger molecules among corporal smooth muscles can approximate, but cannot exceed, the predicted diffusion pro®le for drug or neurotransmitter in the extracellular space (see Ref. 54, 55) . This is an important point, because it indicates that in theory the intercellular and extracellular passive diffusion pathways are roughly equivalent. However, there is a compelling amount of clinical and experimental data on the human corpora, and in other vascular tissues, 3, 11, 13, 20 ,37±42,55 all of which point to the fact that the physiologically important pathway is likely to be the intercellular pathway.
Perhaps this conclusion is not surprising in light of the fact that there are many aspects of the in situ tissue environment that act to severely restrict the extracellular diffusion of neurotransmitters. For example, one must take into account tissue tortuosity factors (namely bundles of smooth muscle cells interspersed in a heavily collagenous extracellular matrix; see Ref. 57) , variations in the distribution of varicosities and their concomitant neuromuscular distances, 57±59 all of which are further exacerbated by the relatively short half-lives and conspicuously small amount of neurotransmitter released during nervous activity. 60 Therefore, it seems certain that the extracellular diffusion pathway is likely to be much more restrictive than the intercellular pathway (see Refs. 11 and 54) .
In addition, all of our modeling to date has been based on the assumption that intercellular diffusion is a passive process, when in fact, there is quite convincing experimental evidence for the presence of regenerative intercellular IP 3 and/or Ca 2 waves in some cell types, 61, 62 including cultured human corporal smooth muscle cells. 20 By de®nition, this would be an`active' process, resulting in greater signal spread (namely larger space constants; see below for de®nition) of second messenger molecules/ions among corporal smooth muscle cells.
The`active vascular unit': an indicator of the extent of signal spread in the human corpora Irrespective of the exact physical nature of the intercellular pathway, it is clear that the passive/ active intercellular spread of second messenger molecules is of great import to the extent of spread of locally restricted neural/hormonal signals among the vast array of largely inexcitable corporal smooth muscle cells. For example, let us consider as aǹ active vascular unit' a group of corporal smooth muscle cells that are within one space constant of a directly activated corporal smooth muscle cell. Speci®cally, this`active vascular unit' would include any cell, in any plane of diffusion (namely 1-D, 2-D or 3-D) in which the intercellular signal originating from the directly stimulated cell (either an electrical or a chemical signal) maintains % 37% of its original value. Taking into account the likelihood that the anatomy of the human corpora favors anisotropic intercellular diffusion (that is, intercellular diffusion would not be expected to be equivalent in all possible directions), as well as the characteristics (width of 5±10 mm; length of 100 mm) of smooth muscle cells in the corpora, the`active vascular unit' would clearly be very dependent on corporal geometry and the extent of neural innervation. It is important to point out that because gap junctional permeability is an order of magnitude less than the cytoplasmic diffusion coef®cient, second messenger molecule diffusion or current ow will always be much greater along the long axis of the smooth muscle cell than perpendicular to the long axis of the cell. Therefore, depending on the precise orientation of the corporal smooth muscle cells in the extracellular matrix, the number of cells in the`active vascular unit' could range from a minimum of tens of cells to a maximum of hundreds of cells. 13, 35 Thus, neurons, endothelial cells or intracorporally injected drugs (for example prostaglandin E 1 ), can all be regarded as point sources for the local activation of groups of corporal smooth muscle cells. Furthermore, the size of the`active vascular unit' would be impacted upon by any ageor disease-related alteration that resulted in signi®-cant changes in the number of nerve terminals, endothelial cells, or corporal smooth muscle cells (for example age-related decreases in smooth muscle, neuronal or endothelial content), or in the amount/ composition of the extracellular matrix (for example the presence of signi®cant ®brosis leading to greater separation of the smooth muscle cells, commensurately smaller areas of cellular apposition, and thus, decreased intercellular coupling).
The`syncytial tissue triad': the mechanistic basis for integrative erectile physiology In summary then, it is clear that no one mechanism is suf®cient to account for all aspects of corporal smooth muscle function. In this scenario, the ANS, intracellular signal transduction mechanisms and intercellular communication through gap junctions all act in concert to ensure the rapid and syncytial corporal smooth muscle response required for normal erectile function. Mathematical modeling analyses that taken into account such diverse factors as innervation density, geometry of innervation (namely one, two, three dimensional), second messenger diffusion/metabolism, and the activity of the autonomic nervous system, 56±59 as well as the distribution, conductance and permeability of the intercellular pathway also support this interpretation. Thus it seems likely that the participation of gap junctions in erectile physiology/disease is most directly related to the`plasticity' that the presence of these ubiquitously distributed channels are likely to confer upon corporal smooth muscle cells. Analogous to the situation in the heart, where the presence of gap junctions is very important to the prevention of conduction defects, the presence of gap junctions in the penis would appear to provide à safety factor' for normal erectile function. Conversely, with respect to erectile dysfunction, the innate redundancy provided by gap junctions ensure that multiple and/or severe derangements would need to occur in order to disrupt erectile function. Drawing another analogy from a distinct literature, the presence of gap junctions in the human corporal ensures that, as in the hypothesis of cancer formation,`multiple hits' would be required to cause erectile dysfunction in this multi-layered system. Summary and conclusions: why is studying the regulation and coordination of corporal smooth muscle tone so important?
As discussed above, understanding the regulation and coordination of corporal smooth muscle tone seems especially relevant in light of the increased ef®cacy and greater availability of contemporary intracavernous injection modalities, and more recently of projected oral therapies. All of these are thought to cause erection by virtue of their ability to either increase the production of (namely prostaglandin E 1 ), or prolong the effects of (papaverine, sildena®l, milrinone) second messenger molecules. Presumably, the ability of microgram quantities of vasoactive compounds injected into one corpora (for example PGE 1 ) to elicit rapid and syncytial erectile responses, is directly related, in large part, to the presence of the intercellular coupling pathway that exists among corporal smooth muscle cells.
Thus, the ef®cacy of any drug or therapy will be directly related to its ability to take advantage of the ubiquitously distributed gap junction channels to reduce the activity of Ca channels, or increase the activity of the K channels present in corporal smooth muscle. Those therapeutic modalities that do so in the most ef®cient and least invasive manner will be the most widely utilized by the medical specialists and the consuming public. As described in detail elsewhere 1 , one attractive way to do so is by the introduction of genes responsible for the synthesis of proteins that regulate the most important facets of corporal smooth muscle tone, eg potassium channels.
